Although this result did not reach statistical significance ( P =0.180), a trend was suggested that MHCC patients with PVTT receiving TACE–PMCT treatment had a longer survival time.
← all excerpts
Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization-percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm).
1
0.1800
0.1800